日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Triple Oral Combination of Bendamustine, Acalabrutinib, and Venetoclax Demonstrates Efficacy Against Mantle Cell Lymphoma In Vitro and In Vivo.

苯达莫司汀、阿卡替尼和维奈托克的三联口服组合在体外和体内均显示出对套细胞淋巴瘤的疗效

Filioglou Dimitrios, Santa-Cruz Nina, Leite Geovana S F, Davini Dan W, Cracchiolo Megan J, Baker Forrest L, Husnain Muhammad, Simpson Richard J, Voudouris Vasilios, Katsanis Emmanuel